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The dicarbene gold(I) complex [Au(9-methylcaffein-8-ylidene)2]BF4 
(I) is an exemplary organometallic compound of outstanding 
interest as a prospective anticancer agent. This gold(I) complex was 
previously reported to be highly cytotoxic in vitro toward various 
cancer cell lines and behave as a tight ligand for human telomeric 
DNA sequences. We have analysed its interactions with various 
telomeric DNA models through a combined ESI MS and XRD 
approach. ESI MS measurements confirmed formation of stable 
adducts between the intact gold (I) complex and Tel 23 DNA 
sequence. Afterward, we solved the crystal structure of the adduct 
formed between [Au(9-methylcaffein-8-ylidene)2]+ and Tel 23 DNA 
G-quadruplex. Notably, Tel 23 maintains a characteristic propeller 
conformation, while binding three gold(I) dicarbene moieties, at two 
distinct sites. Stacking interactions appear to drive noncovalent 
binding of this gold(I) complex. The structural bases for tight 
gold(I) complex /G-quadruplex recognition and for its selectivity are 
thus unveiled. 
 Gold compounds, either 3+ or 1+, form a new class of 
inorganic medicinal agents of great interest for cancer treatment 
owing to the occurrence of innovative modes of action[1]. To this 
regard it is worth mentioning that the established anti-arthritic gold 
drug auranofin has recently been repurposed as  a candidate 
anticancer agent and is currently undergoing evaluation in three 
distinct US clinical trials[2]. Pairwise, other gold(I) agents and, 
specifically, a number of monocarbene and dicarbene gold(I) 
complexes, seem quite promising as they manifest relevant 
cytotoxic properties while being acceptably stable under 
physiological like conditions[3]. This behaviour might result into a 
higher cancer selectivity and a lower systemic toxicity compared to 
other cytotoxic gold drugs typically manifesting a larger and more 
general reactivity with biomolecules.  
The modes of action of cytotoxic gold(I) compounds are still a 
matter of intense debate. However, there is now quite a wide 
consensus on the concept that they diverge profoundly from those of 
cisplatin and analogues, mainly grounded on a documented,  poor 
reactivity with double helix DNA; on the other hand, there is good 
evidence that they often produce severe mitochondrial damage[1]. 
Nonetheless, alternative modes of action beyond mitochondrial 
insult have been proposed to explain their cytotoxicity, including  
proteasome inhibition and antitelomerase activity, within a probable 
multi-target scenario.  
The latter hypothesis – i.e. a pronounced antitelomerase activity 
– distinctly emerges from previous studies on auranofin[4]. Small 
molecules, that are able to bind and block telomerase manifest, in 
general, remarkable anti-cancer properties. In turn, the G-
quadruplex binding properties well correlate with antitelomerase 
activity[5]. 
G-quadruplexes (also known as G4) are nucleic acid sequences, 
rich in guanines, capable of forming a characteristic four-stranded 
fold[6]. Four guanine bases may associate through Hoogsteen 
hydrogen bonding to produce a square planar motif, the so called 
“guanine tetrad”; two or more guanine tetrads can stack on top of 
each other to form a G-quadruplex. The quadruplex structure is 
further stabilized by the presence of monovalent cations, which lie 
in the central channel between each pair of tetrads[7].  
Human telomeric DNA consists of tandem repeats of the 
hexameric sequence d(TTAGGG), located at the 3’-ends of 
chromosomes; the quadruplexes that arise from these repeats were 
described in detail thanks to NMR and X-ray diffraction structural 
determinations[8-11]. Interestingly, the formation of quadruplexes 
causes a net decrease in the activity of the enzyme telomerase, 
responsible for maintaining the length of telomeres[12]. Therefore, 
molecules that template the formation or stabilize the structure of G-
quadruplex DNA might pave the way to the development of new 
effective anticancer drugs, based on selective telomerase 
inhibition[13-16].  
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ŧ        Tel 23-[Au(9-methylcaffein-8-ylidene)2]
+ complex: a= 47.13 Å, 
          b= 51.29 Å, c =58.77 Å, space group I212121, Resolution 1.9 Å,  
Rsym 0.069, Completeness 97.8%. Details of the crystallization, 
data collection and model refinement are reported in ESI. Protein 
coordinates have been deposited in the Protein Data Bank (PDB 
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While the majority of quadruplex DNA binders reported to date 
contain planar organic heteroaromatic systems, a variety of metal 
complexes, mostly bearing extended planar motifs, were also shown 
to exhibit large affinities for DNA G-quadruplexes[5,17,18]. An 
extensive overview of this topic is provided in two recent review 
articles where a number of relevant examples are illustrated[19,20]. 
Yet, relatively scarce structural information is available on the 
adducts formed between metal complexes and G4-DNA which 
would be of great help to develop selective G4 stabilizers: crystal 
structures have been reported so far only for the adducts of 
copper(II) and nickel(II) salphen complexes with human telomeric 
DNA[21]. Also, extremely scarce information on the interactions of 
gold compounds with G4-DNA is available[22,23]. The above 
arguments prompted us to explore, at a molecular level, the 
interactions taking place between organometallic gold(I) N-
heterocyclic carbene (NHC) compounds and  a representative DNA 
G-quadruplex – i.e. the one arising from Tel23 sequence – through a 
combined ESI MS and X-ray diffraction investigative strategy. 
Based on recent work by some of us[22], we selected for this study 
the bis-carbene cationic complex [Au(9-methylcaffein-8-ylidene)2]+, 
complex I (Figure 1), which was  earlier reported to be  a selective 
cytotoxic agent in cancer cells. This compound is able to bind quite  
strongly a few representative G4-DNAs, more selectively than DNA 
duplexes, as well as 3- and 4-ways junctions[23]. The occurring 
interactions were mainly characterized by spectrofluorimetric 
methods but no structural data have been obtained so far for these 
systems.  
Notably, the chemical features of the mentioned dicarbene 
gold(I) complex fully fulfil the basic requirements for an ideal G4 
ligand: i) it is planar;  ii) it is positively charged and thus prone to 
electrostatic interactions with negatively charged DNA; iii) it has 
two aromatic caffeine ligands (i.e. a guanine analogue) which can 










+ cation (complex I) 
investigated in this study. 
 
 Mass spectrometry methods offer today a very powerful and 
straightforward tool to characterize metal binding to G-quadruplexes, 
at a molecular level; the suitability of ESI MS for these systems was 
recently highlighted[24]. The ESI MS spectrum of a solution 
containing  both complex I and Tel 23 sequence shows three main 
peaks, assigned  to complex I /Tel 23 adducts of various  
stoichiometries (1:1, 2:1 and 3:1 respectively) (Figure 2). It is 
inferred that complex I binds Tel 23 as the intact [Au(9-
methylcaffein-8-ylidene)2]+ cation, at various molar ratios (up to a 
maximum of 3:1). The ammonium ion, promoting the G-quadruplex 
assembly, is also accommodated inside the structure (see ESI-Table 







Figure 2. Section of the ESI-MS spectra of Tel23/[Au(9-methylcaffein-
8-ylidene)2]BF4 25 µM in water in the presence of 60% EtOH, 3:1 metal 
complex:G4 molar ratio. 
 
Afterward, crystals of the Tel23/[Au(9-methylcaffein-8-
ylidene)2]+ adduct were grown and analyzed by X-ray diffraction 
(orthorhombic system, space group I212121)ŧ. The overall 
organization of the adduct in the crystal (Figure 3) reveals the 
quadruplex in the parallel-stranded arrangement. The TTA loops are 
better described by using the type-9 topology (see ESI-Table S3-4), 
on the basis of the classification made by Collie and coworker[11]. 
The parallel topology results in accessible external 5' and 3' planar 
G-tetrad surfaces for ligand stacking. The quadruplex units, 
symmetry related by 2-fold rotation axes, repeat themselves in the 
crystal determining columns growing in the [010] direction. Along 
these columns, [Au(9-methylcaffein-8-ylidene)2]+ ions are found at 
each interface between the adjacent 2-fold symmetry related 
quadruplexes, stacked on their external tetrads at about 3.4 Å. 
Noteworthy, the present structure evidences that complex I binding 
is possible at the 3’-3’ (3’end-3’end) site, as well as at the 5’-5’ 
(5’end-5’end) site. Interestingly, these sites differ for the relative 
arrangement of the two tetrads, almost perfectly coplanar in the 5’-
5’ site and tilted with respect to each other in the 3’-3’ one, the G17 
and G23 forming a dihedral angle of about 38° (Figure 3c). 
Moreover, the two binding sites also differ for the overall number of 
hosted metal complexes: either one or two [Au(9-methylcaffein-8-
ylidene)2]+ ions are located in the 3’-3’ and 5’-5’ sites, respectively 
(Figure 3a,c). It is worth mentioning that the number of complexes 
directly stacked on each single quadruplex unit is the same found in 
solution by the ESI mass measurements, so reinforcing the 
hypothesis for a maximal 3:1 gold/quadruplex binding stoichiometry. 
The stacked [Au(9-methylcaffein-8-ylidene)2]+ ions, at each binding 
site, adopt a planar arrangement, with the linear geometry 
commonly expected for a two-coordinated Au(I) complex. Overall, 
the structure found for each metal complex is quite similar to that 
previously obtained in the [Au(9-methylcaffein-8-ylidene)2][BF4] 
crystal structure[22] . Interestingly, the caffeine ligands bound to the 
Au(I) ion are less prone to undergo ligand exchange reactions than, 
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for example, chlorido and N-donor ligands, therefore, preventing the 





Figure 3. (a) 5’-5’ end binding site of the Tel 23:[Au(9-methylcaffein-8-
ylidene)2]+ adducts; (b) columnar disposition of the propeller Tel 23:[Au(9-
methylcaffein-8-ylidene)2]+ adducts featuring the overall crystal packing; 
(c) 3’-3’ end binding site of the Tel 23:[Au(9-methylcaffein-8-ylidene)2]+ 
adducts, with indication of the dihedral angle formed by symmetry related 
G17 and G23 residues. All interplanar distances (dashed lines) are ca. 3.4 Å. 




The 2-fold symmetry, featuring the binding sites, also applies to 
complex I: in the 3’-3’ end site the metal ion perfectly lies on the 
crystallographic axis while the caffeine units are disordered and 
shared between the 2-fold symmetry related positions (Figure ESI-
S2). In the 5’-5’ site both stacked [Au(9-methylcaffein-8-ylidene)2]+ 
ions place their metal center near, but not above, the 2-fold axis 
(Figure 4). This kind of 2-fold pseudo-symmetric disorder is rather 
common, having been found in several of the crystal structures 
reported so far for human telomeric quadruplex/ligand adducts[25-28], 
and it is irrespective of the nature of the interacting ligand. This 
observation supports the view that binding processes are mainly 
driven by adirectional forces, such as electrostatic, Van der Waals 
and π-π stacking interactions, which, require broad contact surfaces. 
Nevertheless, as clearly shown in Figure 4 and Figure ESI-S2, 
only one caffeine unit, out of two potentially available per metal 
complex, interacts with the guanine residues, the other one 
protruding outside and giving little or almost no overlap with the 
tetrad. Actually, the [Au(9-methylcaffein-8-ylidene)2]+ ion is longer 
than the tetrad side, but it could give a good dimensional matching 
with the tetrad diagonal (about 16 Å for both the metal complex and 
the tetrad diagonal vs. 11 Å for the tetrad side). In the 3’-3’ end site, 
the 38.5° dihedral angle formed by the symmetry related G17 and 
G23 residues (Figure 3c) prevents the [Au(9-methylcaffein-8-
ylidene)2]+ ion to be diagonally located (Figure 3c). However, in the 
5’-5’ end site, the tetrad is completely available, and one can only 
suppose that the partial coordination of two metal complexes 
provides a greater extent of stabilization than the stacking of two 
caffeines belonging to only one metal compound in diagonal 
position with respect to the guanine tetrad. In this respect, it should 
be noted that all the gold(I) centers in the Tel23:[Au(9-
methylcaffein-8-ylidene)2]+ adduct are far from the central channel 
defined by the guanine carbonyl oxygens. Instead, they are always 
sandwiched between two pyrimidine rings, one from each 
symmetric guanine tetrad, at about 3.5 Å from a nitrogen atom 
(Figure 4) or from a carbon atom (Figure ESI-S2). This feature 
highlights a significant difference from the salphen metal complexes 
previously reported by Campbell et al.[21], where the metal centers 
are placed almost in line with the central ion channels, without 
specific contact with the quadruplex unit. 
 
Figure 4. Structural details for the gold(I) complex in the 5’-5’ binding site 
 
It should be mentioned that the symmetric binding sites found in the 
Tel 23:[Au(9-methylcaffein-8-ylidene)2]+ adduct could not be 
formed by adjacent quadruplex units along the same telomeric 
polymer. Nevertheless, the actual structure for human telomeric 
DNA in vivo is still unknown, and different kinds of higher-order 
arrangements, afforded by non-consecutive G-quadruplexes 
belonging to long telomeric sequences, should be taken into 
account, which may still produce the observed adducts. 
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In conclusion, we have described here, through a joint ESI-MS and 
XRD investigation, the adduct formed between a human telomeric 
DNA G-quadruplex and a cationic gold(I) dicarbene complex. In 
agreement with ESI-MS results, XRD data evidence that  three 
gold(I) complexes binds the G quadruplex at two distinct sites. 
Details of the contacts between the metal complex and DNA G-
quadruplex were carefully analyzed to dissect the molecular basis of 
such tight interaction. Interestingly, the greater selectivity of [Au(9-
methylcaffein-8-ylidene)2]+ for DNA G-quadruplex structures over 
double helix DNA can be tentatively explained as follows. Actually, 
the double helix base pair, dimensionally similar to a G4 tetrad side, 
is too short in comparison to the elongated size of our gold(I) 
complex. In ds-DNA the phosphate backbones limit the space 
available to a parallel intercalating ligand. Instead in Tel 23:[Au(9-
methylcaffein-8-ylidene)2]+ adduct, only one caffeine unit per 
ligand molecule interacts with the guanine residues, while the other 
one protrudes outside the tetrad surface, which in the all parallel 
propeller folding is not hindered by lateral or diagonal loops. 
Overall, the reported results shed further light into the possible 
mechanisms of anticancer activity of complex I, for which G4-DNA 
seems to be a relevant pharmacological target and inhibition of the 
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